Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 141 No. 2526 (2011)

Knowledge of oral drug treatment in immunocompromised patients on hospital discharge

  • I Chau
  • V Korb-Savoldelli
  • L Trinquart
  • T Caruba
  • P Prognon
  • P Durieux
  • C Piketty
  • B Sabatier
DOI
https://doi.org/10.4414/smw.2011.13204
Cite this as:
Swiss Med Wkly. 2011;141:w13204
Published
20.06.2011

Summary

PRINCIPLES: Several studies have shown that patients’ inappropriate knowledge about their medication is associated with non-adherence. The aim of this study was to assess immunocompromised inpatient knowledge of their oral drug treatment on discharge.

METHODS: We conducted a single-centre, prospective, cross-sectional study from July to November 2008 in the Immunology unit of a university-based hospital. Knowledge of all oral prescribed medication was assessed before discharge of immunocompromised inpatients using a self-administered questionnaire, assessing drug name, dosage, indication and administration guidelines. Prescribed drugs were classified as treatments for chronic disease, or as adjuvant treatments which were differentiated regarding their link with the chronic disease.

RESULTS: Over four months, 17 transplant recipients and 38 HIV-infected patients were included. Overall, 57% of the 497 prescribed drugs were adequately known. The proportions of drugs adequately known were 79%, 91%, 81% and 62% respectively for the drug name, dosage, indication and administration guidelines components. Drugs for the treatment of chronic disease were more adequately known than adjuvant treatments. Older age and a low educational level were significantly associated with poor knowledge of drugs.

CONCLUSIONS: Immunocompromised patients demonstrated moderate to good knowledge of oral drugs on discharge. Adjuvant treatments were less well known than drugs for the treatment of chronic disease. Some recommendations for interventions aimed at utilising the skills of clinical pharmacists are needed. Efforts which encourage patients to be active participants in their own treatment could improve therapeutic adherence and reduce potential complications.

References

  1. Swanson MA, Palmeri D, Vossler ED, Bartus SA, Hull D, Schweizer RT. Noncompliance in organ transplant recipients. Pharmacotherapy. 1991;11(6):173S–174S.
  2. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S98–102.
  3. Singh N, Berman SM, Swindells S, Justis JC, Mohr JA, Squier C, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29(4):824–30.
  4. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002;7(3):185–93.
  5. Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14(12):1089–101.
  6. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am. 2007;36(4):937–63; viii.
  7. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;50(5):499–505.
  8. Tran TM, Van den Neucker A, Hendriks JJ Forget P, Forget PP. Effects of a proton-pump inhibitor in cystic fibrosis. Acta Paediatr. 1998;87(5):553–8.
  9. Dartnell JG, Anderson RP, Chohan V Galbraith KJ, Lyon ME, Nestor PJ, et al. Hospitalization for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust. 1996;164(11):659–62.
  10. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.
  11. O’Neil CK, Poirer TI. Impact of patient knowledge, patient-pharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy. 1998;18(2):333–40.
  12. Tuldra A, Fumaz CR, Ferrer MJ, Bayés R, Arnó A, Balagué M, et al. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25(3):221–8.
  13. Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ. 1995;310(6989):1229–31.
  14. Micheli P, Kossovsky MP, Gerstel E, Louis-Simonet M, Sigaud P, Perneger TV, et al. Patients’ knowledge of drug treatments after hospitalization: the key role of information. Swiss Med Wkly. 2007;137(43-44):614–20.
  15. Louis-Simonet M, Kossovsky MP, Sarasin FP, Chopard P, Gabriel V, Perneger TV, et al. Effects of a structured patient-centered discharge interview on patients' knowledge about their medications. Am J Med. 2004;117(8):563–8.
  16. Maniaci MJ, Heckman MG, Dawson NL. Functional health literacy and understanding of medications at discharge. Mayo Clin Proc. 2008;83(5):554–8.
  17. Esposito L. The effects of medication education on adherence to medication regimens in an elderly population. J Adv Nurs. 1995;21(5):935–43.
  18. Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly? Evaluation of an in hospital program. Patient Educ Couns. 1990;16(2):151–60.
  19. Golay A, Lagger G, Chambouleyron M, Carrard I, Lasserre-Moutet A. Therapeutic education of diabetic patients. Diabetes Metab Res Rev. 2008;24(3):192–6.
  20. Halloran J. Increasing survival with HIV: impact on nursing care. AACN Clin Issues. 2006;17(1):8–17.
  21. Schneider S, Winsett RP, Reed L, Hathaway DK. Use of structured self-monitoring in transplant education. Prog Transplant. 2001;11(2):133–6.
  22. Vidal 2009: Le dictionnaire. 85e édition ed. 2009, Paris: Edition du Vidal.
  23. Rao J, Scott A. A simple methode for the analysis of clustered binary data. Biometrics. 1992;48:577–85.
  24. Hardin J, Hibe J. Generalized Estimating Equations. Chapman and Hall/CRC ed. 2003; Boca Raton, FL.
  25. Holloway A. Patient knowledge and information concerning medication on discharge from hospital. J Adv Nurs. 1996;24(6):1169–74.
  26. Dhote R, Bergmann JF, Leglise P Hathaway DK, et al. Orocecal transit time in humans assessed by sulfapyridine appearance in saliva after sulfasalazine intake. Clin Pharmacol Ther. 1995;57(4):461–70.
  27. Makaryus AN, Friedman EA. Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005;80(8):991–4.
  28. McCormack PM, Lawlor R, Donegan C, O’Neill D, Smith S, Moroney C, et al. Knowledge and attitudes to prescribed drugs in young and elderly patients. Ir Med J. 1997;90(1):29–30.
  29. Shen Q, Karr M, Ko A, Chan DK, Khan R, Duvall D. Evaluation of a medication education program for elderly hospital in-patients. Geriatr Nurs. 2006;27(3):184–92.
  30. Ragot S, Sosner P, Bouche G, Guillemain J, Herpin D. Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey. J Hum Hypertens. 2005;19(7):577–84.
  31. Taylor FC, Ramsay ME, Tan G, Gabbay J, Cohen H. Evaluation of patients' knowledge about anticoagulant treatment. Qual Health Care. 1994;3(2):79–85.
  32. Denes E, Rogez JP, Weinbreck P. Do HIV patients know their treatment?. Med Mal Infect. 2006;36(7):375–8.
  33. Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health. 1979;69(1):47–52.
  34. Partovi N, Chan W, Nimmo CR. Evaluation of a patient education program for solid organ transplant patients. Can J Hosp Pharm. 1995;48(2):72–8.